Audience
Operations, planning and IT leaders at manufacturers in automotive, semiconductor, aerospace and defense, high-value electronics assembly, and medical device.
About Eyelit APS
Eyelit APS performs multi-zone production sequencing — for example Body, Paint, and Trim — optimized holistically in a single run, and models re-entrant flows, merges, splits, buffers, and differing line speeds across zones. Eyelit APS replans with memory: when demand or supply changes, it minimizes disruption to the existing schedule, with the degree of allowed change configurable at any level or attribute.
Eyelit APS provides a wide range of constraint types to model any company's business rules, including feature-combination limits, dynamic spacing, run-lengths on sub-sequences, sequence-dependent setup times, and inventory simulation during sequencing. Eyelit APS delivers Available-to-Promise and Capable-to-Promise in both batch and real-time modes, with the real-time module connecting to the order management system.
Pricing
Integrations
Company Information
Product Details
Eyelit APS Frequently Asked Questions
Eyelit APS Product Features
APS
Production Scheduling
Eyelit APS Verified User Reviews
Write a Review-
Probability You Would Recommend?1 2 3 4 5 6 7 8 9 10
"Enhancements" Posted 2021-10-07
Pros: No need major enhancements, in general our set up since the adoption we covered the most of the features needed.
Cons: When it is needed, it could take some time to get any enhancement.
Overall: As the production plan was getting more complex due to diversity of models and adjustments, we needed a more flexible system that could support such operations, the current system seems to have what is needed.
Read More... -
Probability You Would Recommend?1 2 3 4 5 6 7 8 9 10
"Flexible tool" Posted 2021-10-06
Pros: This solution has multiple configurable features that can adopt to business needs, and it is flexible to config changes.
Cons: Sometimes more training and more support is needed.
Overall: Happy to have Optessa tool.
Read More...
- Previous
- You're on page 1
- Next